AzTrials
AzTrials

Osteo Arthritis Knee and HipSLEEPFITNCT07532070

COMPARATIVE EFFECTIVENESS OF EXERCISE, COGNITIVE BEHAVIOURAL THERAPY, AND THEIR COMBINATION FOR PEOPLE WITH CHRONIC MUSCULOSKELETAL PAIN AND POOR SLEEP: SLEEPFIT TRIAL

A study testing Aerobic physical activity, CBT-I and Combined aerobic physical activity and CBT-I in people with Osteo Arthritis Knee and Hip and Low Back Pain, run by University of Sydney at 4 sites in 2 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to find out which lifestyle approach works best for people with chronic musculoskeletal pain (such as low back pain or hip/knee osteoarthritis) who also have poor sleep. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Aerobic physical activity, CBT-I and Combined aerobic physical activity and CBT-I
Could I receive a placebo?
No, everyone receives an active treatment
How many people
384 participants
Where
4 sitesin 2 countries
Study dates
Apr 2026to Apr 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • Self-report engagement in >120 minute per week of at least moderate intensity physical activity within the past 6 months
  • Current or previous engagement in CBT-I in the past 6 months
  • Cognitive impairment (based on ≥7 on the Short Orientation Memory Concentration Test
  • Received an injection of any substance into the study pain site in the previous 3 months
  • Waiting or planning to receive an injection in the study pain site in the next 12 months
  • Had within the past 12 months, or waiting or planning surgery in the next 12 months
Show all 10Show fewer
  • Neurological or systemic conditions that may affect physical function (e.g. Parkinson's, Active cancers, multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis)
  • Failing the American College of Sports Medicine pre-participation Health Screening Questionnaire without medical clearance to participate
  • Unable to give informed consent and/or participate in the intervention and assessment procedures.
  • Unable to speak or read English.

Trial locations and contacts

4 sites in 2 countries. Contact the study team or a site near you to ask about taking part.

Alan A Nguyen, BSc/B.A contact

+610433014884

sleepfit.trial@sydney.edu.au

Michelle Hall, PhD, MSc, BSc (Hons) contact

+61 432128223

michelle.hall@sydney.edu.au

4 sites in 2 countries

United States2 sites, 2 recruiting
  • Madigan Army Medical Centre 9040A Jackson Ave Joint Base

    San Antonio, Nevada, 78234

    Daniel Rhon, daniel.rhon@usuhs.edu

    Rachel Mayhew, rachel.j.mayhew.ctr@health.mil

    Not yet recruiting
  • Brooke Army Medical Centre 3551 Roger Brooke Dr. Fort Sam Houston

    San Antonio, Texas, 78234

    Daniel Rhon, daniel.rhon@usuhs.edu

    Rachel Mayhew, rachel.j.mayhew.ctr@health.mil

    Not yet recruiting

Other trials in United States

Australia2 sites, 2 recruiting
  • The University of Queensland Therapies Building (84A)

    Brisbane, Saint Lucia, 4072

    David Klyne

    Camille Thomas, camillemaeva.thomas@uq.edu.au

    Not yet recruiting
  • Susan Wakil Health Building

    Camperdown, New South Wales, 2200

    Michelle Hall, PhD, MSc, BSc (Hons)

    Recruiting

Other trials in Australia

About this study

This study aims to find out which lifestyle approach works best for people with chronic musculoskeletal pain (such as low back pain or hip/knee osteoarthritis) who also have poor sleep. Participants will be randomly assigned to one of three 12-month home-based programs: exercise, cognitive behavioral therapy for insomnia (CBT-I), or a combination of both. Each program includes up to 10 online sessions with a physiotherapist and guidance on managing pain, sleep, and physical activity. We will measure changes in pain, sleep quality, and overall health using questionnaires, wearable devices, sensory tests, and blood samples. The goal is to improve understanding of non-medication treatments for pain and sleep problems.

Read the detailed description

Chronic musculoskeletal pain, such as low back pain and osteoarthritis of the hip or knee, is common and often associated with poor sleep, reduced function, and lower quality of life. Lifestyle factors like exercise and sleep management can influence pain and well-being, but it is unclear which approach works best for people with both chronic pain and sleep problems.

This randomized controlled trial will compare the effectiveness of three 12-month home-based lifestyle interventions:

Exercise program Cognitive Behavioral Therapy for Insomnia (CBT-I) Combination of exercise and CBT-I

Participants will be adults with chronic low back pain and/or hip or knee osteoarthritis lasting at least 6 months, who also report poor sleep. Eligible participants will be randomly assigned to one of the three groups. All groups will receive up to 10 online consultations with a physiotherapist over 9 months, plus tailored guidance on pain, sleep, and physical activity.

Assessments will occur at baseline, 2 months, 6 months, and 12 months, and will include:

Online questionnaires on pain, sleep, and quality of life Wearable activity and sleep monitoring Sensory testing Blood samples to explore biological markers related to pain and sleep Sleep EEG recordings at baseline and 6 months

The primary aim is to determine which lifestyle intervention provides the greatest improvement in pain and sleep outcomes. Secondary aims include understanding changes in physical function, mood, and biological markers. Findings will help guide future non-medication treatments for people with chronic pain and sleep difficulties.

Being tested
Aerobic physical activity, CBT-I, Combined aerobic physical activity and CBT-I
Keywords
Chronic musculoskeletal pain, Low back pain, Hip osteoarthritis, Knee osteoarthritis, Poor sleep, Insomnia, Cognitive Behavioral Therapy for Insomnia (CBT-I), Exercise therapy, Lifestyle intervention, Non-pharmacological treatment, Randomized controlled trial, Sleep quality, Pain management, Physiotherapy, Wearable activity monitor, Sleep EEG
Medical subject headings
Low Back Pain, Sleep Initiation and Maintenance Disorders, Osteoarthritis, Hip, Osteoarthritis, Knee, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aerobic physical activityBehavioural

    This intervention consists of a structured, individualised aerobic physical activity program delivered via videoconferencing by a physiotherapist. The program focuses exclusively on aerobic-based activities and does not include any sleep-specific or cognitive behavioural components. Exercise prescription will be tailored and progressively adjusted based on participant tolerance, goals, and clinical guidelines.

  • CBT-IBehavioural

    This intervention consists of cognitive behavioural therapy for insomnia (CBT-I) delivered via videoconferencing by a physiotherapist trained in CBT-I principles. The program targets sleep-related behaviours and cognitions using evidence-based CBT-I strategies, including sleep restriction, stimulus control, cognitive restructuring, and sleep hygiene education. No structured physical activity or exercise prescription is included.

  • Combined aerobic physical activity and CBT-IBehavioural

    This intervention integrates both a structured aerobic physical activity program and cognitive behavioural therapy for insomnia (CBT-I) within the same physiotherapist-delivered videoconferencing consultations. Participants receive both aerobic physical activity alongside CBT-I strategies targeting sleep behaviours and cognitions. The combined intervention delivers both components concurrently and differs from the single-component interventions by addressing physical aerobic activity and sleep within an integrated treatment framework.

Study groups in NCT07532070
Study groupRoleWhat they receive
Aerobic physical activityExperimentalNot described
Receives: Behavioral: Aerobic physical activity
CBT-IExperimentalCognitive behaviour therapy for insomnia
Receives: Behavioral: CBT-I
combined aerobic physical activity and CBT-IExperimentalcombined aerobic physical activity and cognitive behaviour therapy for insomnia
Receives: Behavioral: Combined aerobic physical activity and CBT-I

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Average Pain severity

    Average pain severity at the designated study site will be measured using a 0-10 Numerical Rating Scale, with higher scores indicating greater pain. Assessments will be conducted at baseline and at 2, 6, and 12 months. Primary intervention efficacy will be evaluated by between-group differences in change in average NRS pain from baseline to 6 months.

    Measured: Baseline and 2, 6 (primary time-point) and 12 months

Secondary outcomes (7)
  1. Worst pain severity

    Worst pain severity at the designated study site over the past week will be assessed using the numeric rating scale, ranging from 0 ("no pain") to 10 ("worst pain possible").

    Measured: Baseline and 2, 6 and 12 months

  2. Pain interference (PROMIS Short Form 8a)

    Scored using 8 questions (5-point Likert Scale) related to the consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities in the past 7 days. 5-point Likert scale. Ranges from 0-10; where 0 = 'no pain' and 10 = 'worst pain possible'

    Measured: Baseline, 2 mths, 6 and 12 months.

  3. Health-related quality of life (EQ-5D-5L)

    Scored using 5 items (5-point Likert Scale) about mobility, self-care, pain, usual activities, and psychological status over the past week, with a Likert scale ranging from no problem to extreme pain or discomfort.Score ranges from 0 to 100. Higher scores indicate a better quality of life.

    Measured: Baseline, 2 mths, 6 and 12 months.

  4. Insomnia (Insomnia Severity Index)

    Scored using a 7-items (5-point Likert scale) that captures disturbances in sleep consistent with insomnia. Score ranges 0 to 28. Higher scores indicating greater insomnia severity.

    Measured: Baseline, 2 mths, 6 and 12 months.

  5. Sleep-related impairment (PROMIS-Sleep-related Impairment Short Form 8a)

    Scored using 8 items (5-point Likert scale) on perceptions of alertness, sleepiness, and tiredness during usual waking hours, and perceived functional impairments during wakefulness associated with sleep or impaired alertness. Ranging from "very poor/not at all" to "very good/very much". Score ranges from 8 to 40. Higher scores indicate greater sleep-related impairments.

    Measured: Baseline, 2 mths, 6 and 12 months.

  6. Physical Function (PROMIS-Physical Function Short Form 8c v2.0)

    Scored using 8 items on 5 point Likert scales, capturing capacity to perform activities such as household chores, walking, climbing stairs, and lifting, as well as whether health limits these activities Ranging from "without any difficulty/not at all" to "unable to do/cannot do". Score ranges from 8 to 40. Higher scores indicate less physical dysfunction.

    Measured: Baseline, 2 mths, 6 and 12 months.

  7. Satisfaction with the intervention

    Self-reported. Evaluation as perceived satisfaction. Ranging from "strongly agree" to "strongly disagree". Score range from 0 to 44 with higher score indicating less satisfaction.

    Measured: 2 mths, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionApr 2028 (estimated)
  4. Study completionApr 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a parallel-group randomized controlled trial comparing three lifestyle interventions for adults with chronic musculoskeletal pain and poor sleep. Participants will be randomly assigned to one of three groups: 1. Aerobic physical activity; 2. Cognitive Behavioral Therapy for Insomnia (CBT-I); 3. Combination of aerobic physical activity and CBT-I
Masking
Single blind
Who is masked
Investigator
Enrolment
384 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07532070
Sponsor's protocol ID
2024/HE001412
Other IDs
HT9425-23-CPMRP-CORA
Acronym
SLEEPFIT
Status last verified
May 2026
First submitted
8 Apr 2026
Last updated
5 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data will be made available upon reasonable request following publication of the primary outcomes. Requests will be reviewed by the study investigators and require a data sharing agreement. Data will be shared for research purposes consistent with participant consent and ethical approvals.

Questions about this trial

What is this clinical trial studying?

A study testing Aerobic physical activity, CBT-I and Combined aerobic physical activity and CBT-I in people with Osteo Arthritis Knee and Hip and Low Back Pain, run by University of Sydney at 4 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States, Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alan A Nguyen, BSc/B.A (+610433014884, sleepfit.trial@sydney.edu.au), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Average Pain severity (time frame: Baseline and 2, 6 (primary time-point) and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in